EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A new immuno-oncology target – SUMOylation

Yuan Chen

Trends in Cancer · 2023-08 · 9 (8) · 606-608

DOI: 10.1016/j.trecan.2023.04.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Cancer, 2023-08. Verfasst von Yuan Chen. Beteiligte Einrichtung: Division of Surgical Sciences, Department of Surgery, UC San Diego Health, La Jolla, CA 92037, USA; Moores Cancer Center, UC San Diego Health, La Jol…. Hauptthemen laut MEDLINE: Sumoylation, Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Pancreatic Cancer Action Network, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has been a paradigm shift in cancer treatment to produce durable responses. Unfortunately, most cancers do not respond to current immunotherapies, and thus, exploring novel mechanisms is crucial. Emerging data now demonstrate that protein modification by the small ubiquitin-like modifiers (SUMO) is a novel target to activate antitumor immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SumoylationNeoplasmsHumansSmall Ubiquitin-Related Modifier ProteinsProtein Processing, Post-Translational

Stichwörter der Autor:innen

NK cellsSUMOT cellscancerdendritic cellsimmunotherapyinnate immunitymacrophages

Substanzen

Small Ubiquitin-Related Modifier Proteins

Autor:innen und Institutionen

  • Division of Surgical Sciences, Department of Surgery, UC San Diego Health, La Jolla, CA 92037, USA; Moores Cancer Center, UC San Diego Health, La Jolla, CA 92037, USA. Electronic address: Yuc020@health.ucsd.edu.

Förderung

  • NCI NIH HHS
  • Pancreatic Cancer Action Network
  • National Institutes of Health

Zitieren

APA

Chen, Y. (2023). A new immuno-oncology target – SUMOylation. Trends in Cancer, 9(8), 606-608. https://doi.org/10.1016/j.trecan.2023.04.010

Vancouver

Chen Y. A new immuno-oncology target – SUMOylation. Trends in Cancer. 2023;9(8):606-608. doi:10.1016/j.trecan.2023.04.010

BibTeX
@article{Chen2023,
  author = {Chen, Yuan},
  title = {A new immuno-oncology target – SUMOylation},
  journal = {Trends in Cancer},
  year = {2023},
  volume = {9},
  number = {8},
  pages = {606--608},
  doi = {10.1016/j.trecan.2023.04.010}
}
Kostenlos starten →